Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in connective, epithelial, and neural tissues. Therapeutic formulations include intra-articular injections (viscosupplementation) for osteoarthritis, topical formulations for dermal repair/hydration, and ophthalmic solutions for dry eye syndrome.
## Primary Indications
* **Osteoarthritis:** Management of knee pain in patients failing analgesics or physical therapy.
* **Ophthalmology:** Dry eye syndrome and ocular surface lubrication.
* **Dermatology:** Skin hydration, wound healing, and dermal filling/aesthetic volumizing.
## Adult Dosing
* **Intra-articular (Knee):** Dosing and frequency vary by product (e.g., Sodium Hyaluronate or Hylan G-F 20).
* *Standard course:* Usually 20 mg/2 mL (single or weekly injections for 3–5 weeks depending on brand protocol).
* *Max dose:* Do not exceed the specific product manufacturer’s recommended cycle per knee joint (typically repeated every 6 months).
* **Ophthalmic:** 0.1% to 0.3% solution; 1–2 drops in affected eye(s) as needed.
* **Topical:** Apply thin layer to affected area 1–2 times daily as needed.
## Pediatric Dosing
* **Safety/Efficacy:** Not established for intra-articular use in pediatric patients.
* **Ophthalmic/Topical:** Generally considered safe when used as directed for dry eye or minor skin irritation, though formal pediatric dosing guidelines are lacking. Professional clinical judgment is required.
## Dose Adjustments
* **Renal/Hepatic:** No formal dose adjustments necessary due to localized site of action/minimal systemic absorption.
* **Geriatric:** No specific adjustments, though increased monitoring for local inflammatory response is recommended.
## Contraindications
* **Hypersensitivity:** Known sensitivity to hyaluronate preparations.
* **Active Infection:** Avoid intra-articular injection if there is an active infection or skin disease in the area of the knee joint.
* **Avian Protein Allergy:** Certain HA products are derived from avian sources (rooster combs); caution in patients with known severe avian/egg allergies.
## Adverse Effects
* **Intra-articular:** Transient pain, joint stiffness, joint swelling, or effusion. Rare but serious: septic arthritis (high index of suspicion required if warmth/erythema develops post-injection).
* **Ophthalmic:** Temporary blurred vision or ocular irritation.
* **Topical:** Rare local site irritation or allergic contact dermatitis.
## Key Drug Interactions
* **Quaternary Ammonium Salts:** Do not use ocular containers or solutions with benzalkonium chloride concomitantly with certain contact lenses if sensitivity is documented.
* **Antiseptics:** Avoid using alcohol or disinfectants containing quaternary ammonium salts for skin preparation prior to injection, as they can precipitate hyaluronic acid.
## Monitoring
* **Intra-articular:** Monitor for signs of local infection (increasing pain, swelling, fever) in the 24–48 hours post-injection.
* **Long-term:** Evaluation of symptom relief and function improvement for osteoarthritis.
## Clinical Pearls
* **Viscosupplementation:** HA does not "cure" osteoarthritis but aims to improve synovial fluid lubrication and shock absorption. Results may take up to 4–6 weeks to manifest.
* **Injection Technique:** Intra-articular injections must be performed under strict aseptic technique to prevent iatrogenic septic arthritis.
* **Product Specificity:** Dosing protocols are highly product-specific. Always verify the individual package insert or institutional protocol for the exact preparation being administered.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice varies by region and institution. Always verify dosages, contraindications, and product-specific administration protocols with the most current manufacturer prescribing information or an institutional formulary prior to use.
